Similar articles for PMID: 32649013

Year	Number of Results
1993	2
1999	1
2001	2
2002	1
2004	4
2006	2
2008	1
2009	1
2010	3
2011	8
2012	4
2013	6
2014	5
2015	10
2016	11
2017	12
2018	15
2019	15
2020	14
2021	21
2022	25
2023	11
2024	0

1

Neuroendocrine differentiation in usual-type prostatic adenocarcinoma: Molecular characterization and clinical significance.

Kaur H, Samarska I, Lu J, Faisal F, Maughan BL, Murali S, Asrani K, Alshalalfa M, Antonarakis ES, Epstein JI, Joshu CE, Schaeffer EM, Mosquera JM, Lotan TL. Kaur H, et al. Prostate. 2020 Sep;80(12):1012-1023. doi: 10.1002/pros.24035. Epub 2020 Jul 10. Prostate. 2020. PMID: 32649013 Free PMC article.

2

Resistance to androgen receptor signaling inhibition does not necessitate development of neuroendocrine prostate cancer.

Brennen WN, Zhu Y, Coleman IM, Dalrymple SL, Antony L, Patel RA, Hanratty B, Chikarmane R, Meeker AK, Zheng SL, Hooper JE, Luo J, De Marzo AM, Corey E, Xu J, Yegnasubramanian S, Haffner MC, Nelson PS, Nelson WG, Isaacs WB, Isaacs JT. Brennen WN, et al. JCI Insight. 2021 Apr 22;6(8):e146827. doi: 10.1172/jci.insight.146827. JCI Insight. 2021. PMID: 33724955 Free PMC article.

3

Transdifferentiation as a Mechanism of Treatment Resistance in a Mouse Model of Castration-Resistant Prostate Cancer.

Zou M, Toivanen R, Mitrofanova A, Floch N, Hayati S, Sun Y, Le Magnen C, Chester D, Mostaghel EA, Califano A, Rubin MA, Shen MM, Abate-Shen C. Zou M, et al. Cancer Discov. 2017 Jul;7(7):736-749. doi: 10.1158/2159-8290.CD-16-1174. Epub 2017 Apr 14. Cancer Discov. 2017. PMID: 28411207 Free PMC article.

4

Immunohistochemistry-based assessment of androgen receptor status and the AR-null phenotype in metastatic castrate resistant prostate cancer.

Gupta S, Vanderbilt C, Abida W, Fine SW, Tickoo SK, Al-Ahmadie HA, Chen YB, Sirintrapun SJ, Chadalavada K, Nanjangud GJ, Bialik A, Morris MJ, Scher HI, Ladanyi M, Reuter VE, Gopalan A. Gupta S, et al. Prostate Cancer Prostatic Dis. 2020 Sep;23(3):507-516. doi: 10.1038/s41391-020-0214-6. Epub 2020 Feb 24. Prostate Cancer Prostatic Dis. 2020. PMID: 32094488 Free PMC article.

5

Lineage plasticity in cancer: a shared pathway of therapeutic resistance.

Quintanal-Villalonga Á, Chan JM, Yu HA, Pe'er D, Sawyers CL, Sen T, Rudin CM. Quintanal-Villalonga Á, et al. Nat Rev Clin Oncol. 2020 Jun;17(6):360-371. doi: 10.1038/s41571-020-0340-z. Epub 2020 Mar 9. Nat Rev Clin Oncol. 2020. PMID: 32152485 Free PMC article. Review.

6

Expression of neuroendocrine differentiation markers in lethal metastatic castration-resistant prostate cancer.

Sainio M, Visakorpi T, Tolonen T, Ilvesaro J, Bova GS. Sainio M, et al. Pathol Res Pract. 2018 Jun;214(6):848-856. doi: 10.1016/j.prp.2018.04.015. Epub 2018 Apr 26. Pathol Res Pract. 2018. PMID: 29728311

7

A first case of ductal adenocarcinoma of the prostate having characteristics of neuroendocrine phenotype with PTEN, RB1 and TP53 alterations.

Kobayashi H, Kosaka T, Nakamura K, Shojo K, Hongo H, Mikami S, Nishihara H, Oya M. Kobayashi H, et al. BMC Med Genomics. 2021 Oct 9;14(1):245. doi: 10.1186/s12920-021-01093-9. BMC Med Genomics. 2021. PMID: 34627261 Free PMC article.

8

Anti-androgen enzalutamide enhances prostate cancer neuroendocrine (NE) differentiation via altering the infiltrated mast cells → androgen receptor (AR) → miRNA32 signals.

Dang Q, Li L, Xie H, He D, Chen J, Song W, Chang LS, Chang HC, Yeh S, Chang C. Dang Q, et al. Mol Oncol. 2015 Aug;9(7):1241-51. doi: 10.1016/j.molonc.2015.02.010. Epub 2015 Mar 5. Mol Oncol. 2015. PMID: 25817444 Free PMC article.

9

Androgen Receptor Splice Variant 7 and Efficacy of Taxane Chemotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer.

Antonarakis ES, Lu C, Luber B, Wang H, Chen Y, Nakazawa M, Nadal R, Paller CJ, Denmeade SR, Carducci MA, Eisenberger MA, Luo J. Antonarakis ES, et al. JAMA Oncol. 2015 Aug;1(5):582-91. doi: 10.1001/jamaoncol.2015.1341. JAMA Oncol. 2015. PMID: 26181238 Free PMC article.

10

Compound Genomic Alterations of TP53, PTEN, and RB1 Tumor Suppressors in Localized and Metastatic Prostate Cancer.

Hamid AA, Gray KP, Shaw G, MacConaill LE, Evan C, Bernard B, Loda M, Corcoran NM, Van Allen EM, Choudhury AD, Sweeney CJ. Hamid AA, et al. Eur Urol. 2019 Jul;76(1):89-97. doi: 10.1016/j.eururo.2018.11.045. Epub 2018 Dec 12. Eur Urol. 2019. PMID: 30553611

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

152 results

Results by year